Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: Steven Rachbach who wrote (353)	11/23/1999 9:25:00 AM
From: RMP	Read Replies (1) \| Respond to of 1127

<As far as the genomics stocks being the "Internet stocks of last year", well, maybe. Neither the Internet stocks (certainly at the start of their run a few years ago) nor the genomic stocks will make big money for years. HGSI is further along than the other "clinical" genomic companies and still will have 2 or 3 years to go until their first drugs come to market. Still, the concept of genomically derived drugs is at least as compelling as the Internet-related businesses and so the HGSI share price may continue to run without any hope of earnings for years.> Maybe so. Still, little pieces such as the one that was broadcast last evening on the CBS Evening News, shed light to the masses on the potential (albeit long-term) of the entire sector. I'm curious if there will be any further bounce following that segment. RMP